数字干预对卒中后失语症患者的疗效:一项系统评价和网络荟萃分析。
完整摘要 · 中文译文
背景:数字干预在改善卒中后失语症(PSA)的语言功能方面显示出潜力,但相互矛盾的证据使最佳策略仍不明确。 目的:本研究旨在评估不同数字干预对PSA患者语言功能和生活质量的影响,并为临床康复决策提供循证支持。 方法:系统检索PubMed、Web of Science、Cochrane Library、Embase、Scopus和中国知网(CNKI)(建库至2026年5月),识别评估数字干预(如虚拟现实[VR]、计算机辅助语言治疗[CALT]、远程康复[TR])用于成人PSA的随机对照试验(RCT)。符合条件的研究报告了西部失语症成套测验或卒中与失语症生活质量量表-39(SAQOL-39)的结局。数据由研究者独立提取。采用Cochrane偏倚风险1(RoB 1)工具评估偏倚风险。使用R 4.5.2进行网状荟萃分析,纳入一致性模型、随机效应模型和I2统计量以评估异质性。通过敏感性分析、亚组分析和荟萃回归分析异质性来源。采用累积排序曲线下面积(SUCRA)对干预疗效进行排序。通过Egger检验和敏感性分析验证稳健性。采用GRADE框架评估证据质量。 结果:共纳入25项RCT,涉及1,069名参与者。与传统治疗(C)相比,VR显示出显著 在失语商(均值差[MD] = 10.77,95% CI 9.48至12.06;SUCRA = 89.57%)、自发言语(MD = 2.35,95% CI 1.71至2.99)、听觉理解(MD = 1.47,95% CI 0.81至2.13)和复述(MD = 1.98,95% CI 1.19至2.76)方面具有优势;排序为VR > CALT>TR > C。在命名方面,CALT排序最高(MD = 1.41,95% CI 0.79至2.03;SUCRA = 89.87%);排序为CALT>VR > C > TR。对于SAQOL-39,VR显示出最佳效果(MD = 0.51,95% CI 0.33至0.70;SUCRA = 96.40%)。排序为VR > TR > C > CALT。 结论:数字干预可有效改善PSA患者的语言功能。VR在失语商、言语、理解、复述和SAQOL-39方面显示出潜在优势,而CALT对命名障碍具有针对性优势。由于研究异质性、偏倚风险和样本量有限,需谨慎解读。未来研究应优化干预方案,整合神经调控或传统治疗技术,并探索具有成本效益的实施策略。 系统评价注册:https://www.crd.york.ac.uk/PROSPERO/view/CRD420261373199,标识符CRD420261373199。
完整摘要 · 英文原文
BACKGROUND: Digital interventions show potential for improving language function in post-stroke aphasia (PSA), but contradictory evidence leaves the optimal strategy unclear. OBJECTIVE: This study aims to evaluate the effects of different digital interventions on language function and quality of life in patients with PSA, and to provide evidence-based support for clinical rehabilitation decisions. METHODS: A systematic search across PubMed, Web of Science, Cochrane Library, Embase, Scopus, and China National Knowledge Infrastructure (CNKI) (inception to May 2026) identified randomized controlled trials (RCTs) evaluating digital interventions (e.g., virtual reality [VR], computer-assisted language therapy [CALT], telerehabilitation [TR]) for adults with PSA. Eligible studies reported Western Aphasia Battery or Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) outcomes. Data were extracted independently. Risk of bias was assessed using the Cochrane Risk of Bias 1 (RoB 1) tool. Network meta-analysis was performed using R 4.5.2, incorporating a consistency model, a random-effects model, and I2statistics to assess heterogeneity. Sources of heterogeneity were analyzed through sensitivity analyses, subgroup analyses, and meta-regression. Intervention efficacy was ranked using Surface Under the Cumulative Ranking Curve (SUCRA). Robustness was validated via the Egger test and sensitivity analyses. Evidence quality was assessed using the GRADE framework. RESULTS: Twenty-five RCTs involving 1,069 participants were included. Compared to conventional therapy (C), VR showed significant superiority in aphasia quotient (mean difference [MD] = 10.77, 95% CI 9.48 to 12.06; SUCRA = 89.57%), spontaneous speech (MD = 2.35, 95% CI 1.71 to 2.99), auditory comprehension (MD = 1.47, 95% CI 0.81 to 2.13), and repetition (MD = 1.98, 95% CI 1.19 to 2.76); Ranking was VR > CALT>TR > C. For naming, CALT ranked highest (MD = 1.41, 95% CI 0.79 to 2.03; SUCRA = 89.87%); Ranking was CALT>VR > C > TR. For SAQOL-39, VR showed the best effect (MD = 0.51, 95% CI 0.33 to 0.70; SUCRA = 96.40%). Ranking was VR > TR > C > CALT. CONCLUSION: Digital interventions effectively improve language function in PSA. VR demonstrated potential advantages for aphasia quotient, speech, comprehension, repetition, and SAQOL-39, whereas CALT provides targeted advantages for naming impairments. Caution is warranted due to study heterogeneity, bias risks, and limited sample sizes. Future research should optimize intervention protocols, integrate neuromodulation or traditional therapeutic techniques, and explore cost-effective implementation strategies. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261373199, Identifier CRD420261373199.